Certainly looking strong, I think the statement from the company yesterday clearly states up the reality of the situation -
Once the mid cycle review comes in as positive, BOT is de-risked which equates to a more realistic valuation of the business, we go from speculation/risk on, to a risk off cash flow positive business.
The fact that SP could become a first line treatment option (after OTC) puts it miles ahead of Qbrexza.
Exciting times for share holders.
Congrats to all!
Bot Chart, page-5765
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $448.9M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3333 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.0¢ | 19510 | 1 |
View Market Depth
| Last trade - 09.42am 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
29.0¢ |
Change
0.000 ( 0.14 %) |
||||
| Open | High | Low | Volume | ||
| 29.0¢ | 29.0¢ | 29.0¢ | 212453 | ||
| Last updated 10.02am 21/05/2024 ? | |||||
| BOT (ASX) Chart |
Day chart unavailable